Clinical Psychology and Neuroscience
Scientific Analyst at the Substance Use, Harms and Responses Unit of the European Union Drugs Agency (EUDA), where I contribute to advancing evidence-based policies and coordinate health and social responses to drug-related challenges.
My work primarily focuses on substance use prevention, and I have experience in other areas of the continuum of care, such as treatment, harm reduction, and the broader health and social consequences of drug use. I hold a PhD in Clinical Psychology and Neuroscience, with over 14 years’ experience working on various aspects of drugs, health psychology, health promotion, and disease prevention from both clinical and research perspectives. My work focusses on developing innovative, evidence-based, and data-driven approaches to improve health and well-being, while reducing the impact of addictive behaviours and non-communicable diseases.
I have authored and co-authored more than 50 peer-reviewed scientific publications on drug use, addictive behaviours, and their physical and mental health consequences. In addition to my research and policy work, I have extensive experience teaching in higher education and providing training for clinical and health professionals, fulfilling one of my greatest passions: sharing knowledge to inspire and empower others to promote better health and care practices. I am deeply committed to the values of the European Union Drugs Agency—scientific excellence, independence, collaboration, and transparency—in supporting Member States and neighbouring countries to design effective, people-centred, and balanced responses to substance use and its associated harms. My professional goal is to contribute to a healthier, more informed, and more resilient society through the integration of research, practice, and policy.